參考文獻(xiàn)/References:
[1] Visser J A.The importance of metabolic dysfunction in polycystic ovary syndrome[J].Nat Rev Endocrinol,2021,17(2):77-78.
[2] Abbott D H,Dumesic D A.Passing on PCOS: new insights into its epigenetic transmission[J].Cell Metab,2021,33(3):463-466.
[3] Gunning M N,Sir Petermann T,Crisosto N,et al.Cardiometabolic health in offspring of women with PCOS compared to healthy controls: a systematic review and individual participant data meta-analysis[J].Hum Reprod Update,2020,26(1):103-117.
[4] Merhi Z,Kandaraki E,Diamanti-Kandarakis E.Implications and Future Perspectives of AGEs in PCOS Pathophysiology[J].Trends Endocrinol Metab,2019,30(3):150-162.
[5] Hansen S L,Svendsen P F,Jeppesen J F,et al.Molecular Mechanisms in Skeletal Muscle Underlying Insulin Resistance in Women Who Are Lean With Polycystic Ovary Syndrome[J].J Clin Endocrinol Metab,2019,104(5):1841-1854.
[6] Lee M H,Yoon J A,Kim H R, et al.Hyperandrogenic Milieu Dysregulates the Expression of Insulin Signaling Factors and Glucose Transporters in the Endometrium of Patients With Polycystic Ovary Syndrome [J].Reprod Sci,2020,27(8):1637-1647.
[7] Naaah S,Hamzah I H,SAR A.Polycystic ovary syndrome dependency on mtDNA mutation; copy Number and its association with insulin resistance[J].BMC Res Notes,2019,12(1):455.
[8] Zhang Y,Zhao W,Xu H,et al.Hyperandrogenism and insulin resistance-induced fetal loss: evidence for placental mitochondrial abnormalities and elevated reactive oxygen species production in pregnant rats that mimic the clinical features of polycystic ovary syndrome[J].J Physiol,2019,597(15):3927-3950.
[9] Whitt J,Woo V,Lee P,et al.Disruption of Epithelial HDAC3 in Intestine Prevents Diet-Induced Obesity in Mice[J].Gastroenterology,2018,155(2):501-513.
[10] Elgamal D A, Abou-Elghait A T,Ali A Y,et al.Ultrastructure characterization of pancreatic β-cells is accompanied by modulatory effects of the HDAC inhibitor sodium butyrate on the PI3/AKT insulin signaling pathway in juvenile diabetic rats[J].Mol Cell Endocrinol,2020,503:110700.
[11] Cho H M,Seok Y M,Lee H A,et al.Repression of Transcriptional Activity of Forkhead Box O1 by Histone Deacetylase Inhibitors Ameliorates Hyperglycemia in Type 2 Diabetic Rats[J].Int J Mol Sci,2018,19(11):3539.
[12] Shi X H,Liu Y,Zhang D Q,et al.Valproic acid attenuates sepsis-induced myocardial dysfunction in rats by accelerating autophagy through the PTEN/AKT/mTOR pathway[J].Life Sci,2019,232:116613.
[13] Hu T,Schreiter F C,Bagchi R A,et al.HDAC5 catalytic activity suppresses cardiomyocyte oxidative stress and NRF2 target gene expression[J].J Biol Chem,2019,294(21):8640-8652.
[14] 常惠, 張多加, 沈文娟, 等.基于中醫(yī)辨證分型的多囊卵巢綜合征分子生物學(xué)特點(diǎn)[J].中國中西醫(yī)結(jié)合雜志,2018,38(11):1398-1401.
[15] 王利紅,徐文婷.首烏僵芪湯治療多囊卵巢綜合征腎虛痰瘀證的臨床研究[J].中醫(yī)藥導(dǎo)報,2016,22(11):73-74,77.
[16] 岑怡,洪慶祥,徐竺婷,等.促排湯對伴胰島素抵抗型多囊卵巢綜合征同型半胱氨酸影響的臨床觀察[J].上海中醫(yī)藥雜志,2016,50(10):56-59.
[17] 張維怡,黃光英,劉潔,等.針刺對多囊卵巢綜合征大鼠不孕的影響[J].中國中西醫(yī)結(jié)合雜志,2009,29(11):997-1000.
[18] 蘇健,白杰,尤瑞紅.針?biāo)幗Y(jié)合治療對肥胖型多囊卵巢綜合征瘦素及胰島素抵抗的影響[J].四川中醫(yī),2014,32(1):86-88.
[19] 潘麗,盧曄,龐麗萍.補(bǔ)腎祛痰化瘀方聯(lián)合二甲雙胍治療多囊卵巢綜合征40例療效觀察[J].甘肅中醫(yī)學(xué)院學(xué)報,2014,31(6):47-48.
[20] 蔣雪霞, 孟君.穴位埋線聯(lián)合鹽酸二甲雙胍片治療腎虛痰濕型多囊卵巢綜合征胰島素抵抗50例臨床觀察[J].河北中醫(yī),2014,36(2):171-174.